ADMA Biologics Stock (NASDAQ: ADMA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 2.804M |
Day Range | - - - |
52 Wk Range | 3.060 - 9.020 |
Market Cap | $2.014B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 83 |
Short Interest | 3.6% |
Days to Cover | 4.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ADMA Biologics (NASDAQ: ADMA) through any online brokerage.
Other companies in ADMA Biologics’s space includes: Twist Bioscience (NASDAQ:TWST), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), Agios Pharmaceuticals (NASDAQ:AGIO) and Dyne Therapeutics (NASDAQ:DYN).
The latest price target for ADMA Biologics (NASDAQ: ADMA) was reported by Raymond James on Friday, May 10, 2024. The analyst firm set a price target for 10.00 expecting ADMA to rise to within 12 months (a possible 15.07% upside). 15 analyst firms have reported ratings in the last year.
The stock price for ADMA Biologics (NASDAQ: ADMA) is $8.69 last updated May 13, 2024 at 6:23 PM EDT.
There are no upcoming dividends for ADMA Biologics.
ADMA Biologics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for ADMA Biologics.
ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.